KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $6.0 billion.

  • Gilead Sciences' Receivables - Net rose 3067.36% to $6.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 3067.36%. This contributed to the annual value of $5.3 billion for FY2024, which is 1414.16% up from last year.
  • According to the latest figures from Q3 2025, Gilead Sciences' Receivables - Net is $6.0 billion, which was up 3067.36% from $5.6 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Receivables - Net ranged from a high of $6.0 billion in Q3 2025 and a low of $3.8 billion during Q1 2022
  • Over the past 5 years, Gilead Sciences' median Receivables - Net value was $5.0 billion (recorded in 2022), while the average stood at $5.0 billion.
  • Per our database at Business Quant, Gilead Sciences' Receivables - Net surged by 5366.31% in 2021 and then tumbled by 1850.66% in 2022.
  • Over the past 5 years, Gilead Sciences' Receivables - Net (Quarter) stood at $5.3 billion in 2021, then increased by 3.52% to $5.5 billion in 2022, then dropped by 14.71% to $4.7 billion in 2023, then grew by 14.14% to $5.3 billion in 2024, then increased by 12.69% to $6.0 billion in 2025.
  • Its Receivables - Net was $6.0 billion in Q3 2025, compared to $5.6 billion in Q2 2025 and $5.3 billion in Q1 2025.